KISPLYX caps 10 mg 30 pce

7680660850028 CH-66085 L01EX08 07.16.1.

Reimbursement limitations:

KISPLYX.01

1L carcinome à cellules rénales avancé (non résécable ou métastatique) présentant un profil de risque …

KISPLYX caps 10 mg 30 pce
KISPLYX caps 10 mg 30 pce
KISPLYX caps 10 mg 30 pce
1 / 3
google

Details

Product number
6608502
CPT
-
Packaging group
30
Unit
Kapsel(n)
Composition
lenvatinibum 10 mg ut lenvatinibi mesilas, calcii carbonas, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum, hydroxypropylcellulosum substitutum humile, talcum, Kapselhülle: hypromellosum, E 171, E 172 (flavum), E 172 (rubrum), Drucktinte: lacca, E 172 (nigrum), kalii hydroxidum, propylenglycolum, pro capsula.

Articles (1)

Kisplyx 10 mg, Kapseln
Kapseln
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
17/10/2025
Professional SmPC
Français
17/10/2025
Professional SmPC
Italien
17/10/2025
Patient information leaflet
Allemand
23/08/2025
Patient information leaflet
Français
23/08/2025
Patient information leaflet
Italien
23/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)

Reimbursement information

Public price
CHF 1376.30
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2025

Authorization holder

Eisai Pharma AG

8050 Zürich

Authorization information

Swissmedic authorization number
66085
Drug name
Kisplyx, Kapseln
Galenic form
KAHA
ATC Code
L01EX08
Authorization status
Z
Dispensation category
A
First authorization
25/08/2017
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Behandlung von fortgeschrittenem Nierenzellkarzinom (RCC)

Packaging details

Description (FR)
KISPLYX caps 10 mg 30 pce
Description (DE)
KISPLYX Kaps 10 mg 30 Stk
Market launch
25/08/2017
Narcotic (BTM)
No

Other packaging sizes

KISPLYX caps 4 mg 30 pce
30 KAP
GTIN: 7680660850011
View